The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBushveld Minerals Regulatory News (BMN)

Share Price Information for Bushveld Minerals (BMN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.60
Bid: 0.55
Ask: 0.65
Change: -0.07 (-10.94%)
Spread: 0.10 (18.182%)
Open: 0.65
High: 0.57
Low: 0.57
Prev. Close: 0.64
BMN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

2 Aug 2023 14:29

RNS Number : 1044I
Bushveld Minerals Limited
02 August 2023
 

2 August 2023

Bushveld Minerals Limited

("Bushveld Minerals", "Bushveld" or the "Company")

Annual General Meeting Results

 

Bushveld Minerals Limited (AIM: BMN), the AIM quoted, integrated primary vanadium producer and energy storage provider, with ownership of high-grade assets in South Africa, announces that all ordinary resolutions put to shareholders at the Annual General Meeting held earlier today were duly passed.

 

No.

ORDINARY RESOLUTIONS

VOTES

IN FAVOUR

AGAINST

WITHHELD

1

To receive and adopt the Annual Financial Statements of the Company and the Directors report and the report of the Auditors for the financial year ended 31 December 2022.

98 533 384

90 204

1 397 262

2

To approve the Directors' fees as reflected in the Remuneration Report and in note 35 of the Annual Financial Statements.

94 251 126

4 821 496

948 228

3

That Messrs RSM UK Audit LLP be reappointed as Auditors to the Company.

98 407 596

565 752

1 047 502

4

That the Directors be authorised to approve the remuneration of the Company's Auditors.

98 188 877

785 554

1 046 419

5

That Michael Kirkwood shall be re-elected as a Director, having retired by rotation and offered himself for re-election.

93 991 307

4 407 531

1 622 012

6

That Kevin Alcock shall be re-elected as a Director, having retired by rotation and offered himself for re-election.

96 996 430

1 402 408

1 622 012

7

That Craig Coltman shall be re-elected as a Director in accordance with Article 140 of the Articles, having been appointed by the Directors in July 2023.

97 963 133

1 036 196

1 021 521

8

The Company be generally and unconditionally authorised for the purposes of Articles 50.3 of the Articles to make on market acquisitions (as defined in Article 50.5 of the Articles) of ordinary shares on such terms and in such manner as the Directors determine provided that:

(i) the maximum aggregate number of ordinary shares which may be purchased is 128,781,828 ordinary shares;

(ii) the minimum price (excluding expenses) which may be paid for each ordinary share is £0.01;

(iii) the maximum price (excluding expenses) which may be paid for any ordinary share does not exceed 105 percent of the average closing

price of such shares for the five business days of AIM prior to the date of purchase; and

(iv) this authority shall expire at the conclusion of the next Annual General Meeting of the Company unless such authority is renewed prior to that time (except in relation the purchase of Ordinary Shares the contract for which was concluded before the expiry of such authority, in which case such purchase may be concluded wholly or partly after such expiry).

97 900 593

733 945

1 386 312

9

The Directors of the Company be and are hereby authorised to exercise all powers of the Company to issue, grant rights to subscribe for, or to convert any securities into, up to 429,272,760 shares (together "Equity Securities") in the capital of the Company being approximately one- third of the issued share capital of the Company (excluding treasury shares) in accordance with Article 8.3 of the Articles of Incorporation of the Company such authority to expire, unless previously renewed, revoked or varied by the Company by ordinary resolution, at the end of the next Annual General Meeting of the Company or, if earlier, at the close of business on the date falling 15 months from the date of the passing of this Resolution, but in each case, during this period the Company may make offers, and enter into agreements, which would, or might, require Equity Securities to be issued or granted after the authority given to the Directors of the Company pursuant to this

Resolution ends and the Directors of the Company may issue or grant Equity Securities under any such offer or agreement as if the authority given to the Directors of the Company pursuant to this Resolution had not ended. This Resolution is in substitution for all unexercised

authorities previously granted to the Directors of the Company to issue or grant Equity Securities; and

92 717 716

5 870 756

1 387 378

SPECIAL RESOLUTIONS

10

If Resolution 9 is passed, the Directors of the Company be and they are hereby authorised to exercise all powers of the Company to issue or grant Equity Securities in the capital of the Company pursuant to the issue or grant referred to in Resolution 9 as if the pre-emption rights contained in Article 9.9 of the Articles of Incorporation of the Company did not apply to such issue or grant provided that: (A) the maximum aggregate number of Equity Securities that may be issued or granted under this authority is 128,781,828 shares, being approximately 10.0 percent of the issued share capital of the Company (excluding treasury shares); and (B) the authority hereby conferred, unless previously renewed, revoked or varied by the Company by special resolution, shall expire at the end of the next Annual General Meeting of the Company or, if earlier, at the close of business on the date falling 15 months from the date of the passing of this Resolution, save that the Company may before such expiry make an offer or agreement which would or might require Equity Securities to be issued or granted after such expiry and the Directors may issue or grant Equity Securities in pursuance of such an offer or agreement as if the authority conferred by the above resolution had not expired. This Resolution is in substitution for all unexercised authorities previously granted to the Directors of the Company to issue or grant Equity Securities in the capital of the Company as if the pre-emption rights contained in Article 9.9 of the Articles of Incorporation of the Company did not apply to such issue or grant.

92 428 510

5 893 134

1 699 206

 

 

Enquiries: info@bushveldminerals.com

Bushveld Minerals Limited

+27 (0) 11 268 6555

Craig Coltman, Chief Executive Officer

Chika Edeh, Head of Investor Relations

SP Angel Corporate Finance LLP

Nominated Adviser & Broker

+44 (0) 20 3470 0470

Richard Morrison / Charlie Bouverat

 

Grant Baker / Richard Parlons

 

 

RBC Capital Markets

Joint Broker

+44 (0) 20 7653 4000

Jamil Miah / Sahil Suleman

 

 

Tavistock

Financial PR

Gareth Tredway / Tara Vivian-Neal/ James Whitaker

+44 (0) 207 920 3150

 

 

ABOUT BUSHVELD MINERALS LIMITED

Bushveld Minerals is a low-cost, vertically integrated primary vanadium producer. It is one of only three operating primary vanadium producers, owning 2 of the world's 4 operating primary vanadium processing facilities. In 2022, the Company produced more than 3,800 mtV, representing approximately three per cent of the global vanadium market. With a diversified vanadium product portfolio serving the needs of the steel, energy and chemical sectors, the Company participates in the entire vanadium value chain through its two main pillars: Bushveld Vanadium, which mines and processes vanadium ore; and Bushveld Energy, an energy storage solutions provider.

Bushveld Energy is focused on developing and promoting the role of vanadium in the growing global energy storage market through the advancement of vanadium-based energy storage systems, specifically Vanadium Redox Flow Batteries ("VRFBs").

 

Detailed information on the Company and progress to date can be accessed on the website www.bushveldminerals.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSSEFDEEDSEEA
Date   Source Headline
26th Jan 20227:00 amRNSQ4 and Full Year 2021 Operational Update
19th Jan 20227:00 amRNSRevised Arrangement on Mustang's VRFB-H Investment
17th Jan 20222:41 pmRNSFurther Update on VRFB-H Investment by Mustang
11th Jan 20223:27 pmRNSUpdate on VRFB Holdings Limited Investment
30th Dec 20217:00 amRNSTermination of Corporate Broker Services
16th Nov 20214:58 pmRNSHolding(s) in Company
8th Nov 20212:12 pmRNSRepayment of Duferco loan note and issue of shares
27th Oct 20217:00 amRNSRepayment of Duferco convertible loan note
21st Oct 20217:00 amRNSQ3 and 9 months 2021 Operational Update
27th Sep 20217:00 amRNSInterim Results for Six Months ended 30 June 2021
20th Aug 20214:24 pmRNSPDMR Dealing to Satisfy Tax Obligations
11th Aug 20213:59 pmRNSHolding(s) in Company
6th Aug 20212:43 pmRNSIssue of Equity PDMR Dealing & Total Voting Rights
5th Aug 20215:00 pmRNSAGM Results
29th Jul 202111:41 amRNSAnnual General Meeting Webcast - Correction
28th Jul 202111:36 amRNSAnnual General Meeting Webcast
21st Jul 20217:00 amRNSQ2 2021 and H1 2021 Operational Update
14th Jul 20217:20 amRNSAnnouncement on Litigation
13th Jul 20217:00 amRNSPosting of accounts and notice of general meeting
7th Jul 202112:05 pmRNSInvestor Presentation
30th Jun 20217:38 amRNSFinal Results for the Year Ended 31 December 2020
14th May 20214:30 pmRNSHolding(s) in Company
14th May 20214:29 pmRNSHolding(s) in Company
14th May 20217:00 amRNSQ1 2021 Operational Update
27th Apr 20217:00 amRNSUpdate on Enerox GmbH Investment
21st Apr 20214:18 pmRNSUnprotected Industrial Action Resolved
19th Apr 20218:42 amRNSUnprotected Industrial Action
1st Apr 20219:04 amRNSHolding(s) in Company
1st Apr 20217:00 amRNSFollow-on investment in Enerox GmbH
30th Mar 20214:25 pmRNSHolding(s) in Company
25th Mar 20211:27 pmRNSHolding(s) in Company
26th Feb 20211:37 pmRNSTotal Voting Rights
25th Feb 20215:56 pmRNSDirector/PDMR Shareholding
19th Feb 20215:43 pmRNSDirector/PDMR Shareholding
19th Feb 20214:41 pmRNSSecond Price Monitoring Extn
19th Feb 20214:36 pmRNSPrice Monitoring Extension
19th Feb 20212:05 pmRNSSecond Price Monitoring Extn
19th Feb 20212:00 pmRNSPrice Monitoring Extension
18th Feb 20216:04 pmRNSDirector/PDMR Shareholding
16th Feb 20215:28 pmRNSDirector/PDMR Shareholding
12th Feb 20213:28 pmRNSHolding(s) in Company
10th Feb 20217:00 amRNSDirector/PDMR Shareholding
8th Feb 20217:00 amRNSQ4 and FY2020 Operational Update - Correction
4th Feb 20217:01 amRNSQ4 and Full Year 2020 Operational Update
4th Feb 20217:00 amRNSVametco Mineral Resources and Reserves update
2nd Feb 20217:00 amRNSHolding(s) in Company
2nd Feb 20217:00 amRNSHolding(s) in Company
1st Feb 20217:00 amRNSEquity Issue, PDMR Dealing & Total Voting Rights
11th Jan 202111:12 amRNSHolding(s) in Company
11th Jan 202110:46 amRNSDeath of Ms Dolly Mokgatle

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.